Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2025-12-25 @ 2:18 AM
NCT ID: NCT05341934
Eligibility Criteria: Inclusion Criteria: * Participants in this study will be patients: * With an alcohol use disorder according to DSM 5 * Follow-up at the Laborit Hospital Center * Aged between 18 and 70 years with informed consent after receiving written information * Engaged in a process to reduce alcohol consumption * With a score of MOCA\> 20 * Whose mother tongue is French * Patients benefiting from social security or benefiting from it through a third party in accordance with the french law on research involving the human person. Exclusion Criteria: * \- Patient with less than 6 Heavy Drinking Days in the month * Patient with Schizophrenia * Patient with bipolar disorder Type 1 * Patient with Korsakoff syndrome or degenerative neurological disorder * Patient with hearing impairment, uncorrected visual impairment * Patient under curatorship or guardianship * Patient with addiction to another substance other than tobacco * Patient already enrolled in another interventional study * Pregnant or nursing woman * Patient with difficulties of expression or comprehension in French * Patients in emergency situations or unable to give their consent. Output Criteria: * Patient who has manifested verbally or in writing, the desire to leave the study in progress. * Patient who will be hospitalized during the study for a problem related to his addiction.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT05341934
Study Brief:
Protocol Section: NCT05341934